Birabresib Uses, Dosage, Side Effects and more
Birabresib is under investigation in clinical trial NCT02698176 (A Dose Exploration Study With MK-8628 in Participants With Selected Advanced Solid Tumors (MK-8628-006)).
Trade Name | Birabresib |
Generic | Birabresib |
Birabresib Other Names | Birabresib |
Type | |
Formula | C25H22ClN5O2S |
Weight | Average: 491.99 Monoisotopic: 491.1182738 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |